OSLO, Norway, April 23, 2024 /PRNewswire/ -- Navamedic ASA (OSE: Nava) will be presenting its 1st quarter 2024 results on Tuesday, April 30, 2024. The presentation will be held at Haakon VIIs gate 2 in Oslo and the event will start at 08.30 CET. A link to the webcast and the presentation will be available through the Navamedic web site on the following link: https://navamedic.com/investors/financial-results/

For further information, please contact:

Kathrine Gamborg Andreassen, CEO, +47 951 78 680 E-mail: kathrine@navamedic.com
Lars Hjarrand, CFO, +47 917 62 842 E-mail: lars.hjarrand@navamedic.com

About Navamedic

Navamedic ASA is a full-service provider of high-quality healthcare products to hospitals and pharmacies. Navamedic meets the specific medical needs of patients and consumers by leveraging its highly scalable market access platform, leading category competence and local knowledge. Navamedic is present in all the Nordic countries, the Baltics and Benelux, with sales representation in the UK and Greece. Navamedic is headquartered in Oslo, Norway, and listed on the Oslo Stock Exchange (ticker: NAVA). For more information, please visit www.navamedic.com

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/navamedic-asa/r/navamedic-asa--invitation-to-2024-1st-quarter-presentation,c3966076

View original content:https://www.prnewswire.co.uk/news-releases/navamedic-asa-invitation-to-2024-1st-quarter-presentation-302124638.html

Tags

More Like This

Navamedic ASA: Invitation to 2023 4th quarter presentation

Navamedic ASA: Invitation to 2023 3rd quarter presentation

Navamedic ASA: Record high quarter with above 50 percent growth

Navamedic Q4 and full year 2023: A year marked by new records and transformative growth initiatives

Navamedic ASA: Minutes of Annual General Meeting

Navamedic Q2 and H1 2024: Stable growth continues and is supported by a new licensing and supply agreement

Navamedic welcomes new shareholders

Navamedic ASA: Amendments to loan agreements with Observe Medical ASA